{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:02:42Z","timestamp":1788912162633,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.parkreldis.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T11:27:30Z","timestamp":1592220450000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy"],"prefix":"10.1016","volume":"76","author":[{"given":"Anna","family":"Santaella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bea","family":"Kuiperij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouke","family":"van Rumund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne A.J.","family":"Esselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.parkreldis.2020.06.004_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.parkreldis.2020.06.004_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.20226","article-title":"Parkinsonian signs and substantia nigra neuron density in decendents elders without PD","volume":"56","author":"Ross","year":"2004","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.06.004_bib3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00702-017-1700-4","article-title":"Differentiation of atypical Parkinson syndromes","volume":"124","author":"Hoglinger","year":"2017","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.06.004_bib4","first-page":"93","article-title":"Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?","volume":"23","author":"Palumbo","year":"2008","journal-title":"Funct. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.06.004_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/CCLM.2011.083","article-title":"S100B protein in neurodegenerative disorders","volume":"49","author":"Steiner","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.06.004_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000106627","article-title":"Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia","volume":"8","author":"Nooijen","year":"1997","journal-title":"Dement. Geriatr. Cognit. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.06.004_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(02)01257-0","article-title":"Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease","volume":"336","author":"Petzold","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"4\u20136","key":"10.1016\/j.parkreldis.2020.06.004_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-5728(85)80063-1","article-title":"Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes","volume":"8","author":"Eng","year":"1985","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.06.004_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in alzheimer's disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J. Alzheim. Dis. : JAD"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.06.004_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jnc.13399","article-title":"Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration","volume":"136","author":"Ishiki","year":"2016","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.parkreldis.2020.06.004_bib11","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00018-006-6094-7","article-title":"Myelin basic protein: a multifunctional protein","volume":"63","author":"Boggs","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.06.004_bib12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neurobiolaging.2006.03.010","article-title":"CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease","volume":"28","author":"Abdo","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.06.004_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00415-014-7568-4","article-title":"Ancillary investigations to diagnose parkinsonism: a prospective clinical study","volume":"262","author":"Aerts","year":"2015","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.06.004_bib14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2020.06.004_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1474-4422(16)00116-2","article-title":"The new definition and diagnostic criteria of Parkinson's disease","volume":"15","author":"Postuma","year":"2016","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.06.004_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2013.07.005","article-title":"MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid","volume":"35","author":"M\u00fcller","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"584","key":"10.1016\/j.parkreldis.2020.06.004_bib17","article-title":"The influence of blood contamination on cerebrospinal fluid diagnostics","volume":"10","author":"Schwenkenbecher","year":"2019","journal-title":"Front. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2020.06.004_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-8981(02)00330-3","article-title":"Measurement of glial fibrillary acidic protein in blood: an analytical method","volume":"326","author":"van Geel","year":"2002","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.parkreldis.2020.06.004_bib19","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/01.STR.31.11.2670","article-title":"Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein","volume":"31","author":"Herrmann","year":"2000","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.parkreldis.2020.06.004_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/mds.10714","article-title":"Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease","volume":"19","author":"Abdo","year":"2004","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.06.004_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.parkreldis.2004.07.002","article-title":"S100B and NSE serum levels in patients with Parkinson's disease","volume":"11","author":"Schaf","year":"2005","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.06.004_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00406-018-0928-9","article-title":"Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson\u2019s disease dementia","volume":"270","author":"Gmitterova","year":"2018","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.06.004_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.870130116","article-title":"Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease","volume":"13","author":"Holmberg","year":"1998","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.06.004_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.parkreldis.2007.02.002","article-title":"CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy","volume":"13","author":"Abdo","year":"2007","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.06.004_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-019-0562-4","article-title":"CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia","volume":"12","author":"Abu-Rumeileh","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.06.004_bib26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3233\/JAD-190550","article-title":"Association of cerebrospinal fluid S100B protein with core biomarkers and cognitive deficits in prodromal and mild alzheimer's disease","volume":"72","author":"Christl","year":"2019","journal-title":"J. Alzheim. Dis. : JAD"},{"issue":"1","key":"10.1016\/j.parkreldis.2020.06.004_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000050753","article-title":"The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia","volume":"46","author":"Fukuyama","year":"2001","journal-title":"Eur. Neurol."},{"issue":"5\u20136","key":"10.1016\/j.parkreldis.2020.06.004_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0197-0186(01)00048-1","article-title":"Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease","volume":"39","author":"Peskind","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.parkreldis.2020.06.004_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-7-6","article-title":"Serum levels of S100B and NSE proteins in Alzheimer's disease patients","volume":"7","author":"Chaves","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.parkreldis.2020.06.004_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp.57.9.1047","article-title":"Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT","volume":"57","author":"Schulz","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.parkreldis.2020.06.004_bib31","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00415-015-7785-5","article-title":"Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes","volume":"262","author":"Lee","year":"2015","journal-title":"J. Neurol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020301693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020301693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:19:41Z","timestamp":1761178781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020301693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":31,"alternative-id":["S1353802020301693"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.06.004","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}